Suven Pharma to acquire controlling stake in Hyderabad-based CDMO Sapala Organic

Suven will initially acquire a 67.5% equity stake of Sapala subject to customary working capital and net debt adjustments, the remaining stake a few months after FY2026-27, as per the terms of the definitive agreements, the company told stock exchanges.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ptfAvkq
via IFTTT